Chemotherapy-induced pulmonary hypertension: role of alkylating agents.
about
Drug Eluting Stents for Malignant Airway Obstruction: A Critical Review of the LiteratureDNA Damage and Pulmonary HypertensionThe cancer theory of pulmonary arterial hypertension.Mechanisms of Cardiotoxicity of Cancer Chemotherapeutic Agents: Cardiomyopathy and Beyond.A case of pulmonary arterial hypertension associated with adult hemophagocytic lymphohistiocytosisEIF2AK4 mutation in pulmonary veno-occlusive disease: A case report and review of the literatureHematological disorders and pulmonary hypertension.The influence of chemotherapy on the right ventricle: did we forget something?Drug-induced pulmonary arterial hypertension: a review.Pulmonary Hypertension and Cancer: Etiology, Diagnosis, and Management.The clinical features of fatal cyclophosphamide-induced cardiotoxicity in a conditioning regimen for allogeneic hematopoietic stem cell transplantation (allo-HSCT).Pulmonary veno-occlusive disease in a pediatric hematopoietic stem cell transplant patient: a cautionary tale.Pulmonary Veno-Occlusive Disease: A Newly Recognized Cause of Severe Pulmonary Hypertension in Dogs.Translating Research into Improved Patient Care in Pulmonary Arterial Hypertension.Pulmonary Veno-occlusive Disease and Pulmonary Hypertension in Dogs: Striking Similarities to the Human Condition.DRUG INDUCED PULMONARY ARTERIAL HYPERTENSION: A PRIMER FOR CLINICIANS AND SCIENTISTS.Diagnosis, Treatment, and Prevention of Cardiovascular Toxicity Related to Anti-Cancer Treatment in Clinical Practice: An Opinion Paper from the Working Group on Cardio-Oncology of the Korean Society of Echocardiography.A simple method to assess in vivo proliferation in lung vasculature with EdU: the case of MMC-induced PVOD in rat.Pulmonary tumor thrombotic microangiopathy and pulmonary veno-occlusive disease in a woman with cervical cancer treated with cediranib and durvalumab.2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
P2860
Q26766244-01B3FE7B-B4EB-449B-94C8-5A1CFBFC2903Q27005594-DFB0815C-8BD0-4722-8775-41E9E02DF5FBQ33788493-D7555F3B-92E1-483D-A2B7-AB2ED975B68AQ37038711-F2ED7D9A-D565-4BAC-AE50-B57D6C4E0A82Q37555401-608A4888-CFC6-48D6-AA31-A0AE044F4038Q37605963-CC2F3B0F-8D8F-48CF-8901-60B1F62B2BC7Q39077582-A156FB1C-95CB-4FD9-B264-BB1DAB412DBCQ39133246-FE9892F7-2FEF-4DEC-BAA5-452AFB649CC6Q39247400-AF897B0F-5DCF-40CD-8FCA-E65136427A41Q39279796-7385E00D-45D5-412C-8B9D-523F1F6BBFCCQ40713867-1127EAE1-0A92-42D4-B3F6-04BE7CC3C1DAQ46052894-1AD0B3A4-25B2-4039-827C-17016FC49125Q46192394-DACCC81E-07D1-4052-A16B-180C7D07B237Q46682354-946CD4CD-36DF-4E24-A2BD-70A87F939B7DQ49214965-FD622647-EF5E-4B4F-974F-1AE80D99A686Q50124360-398F50BC-5F25-49D1-B023-4456A6073303Q53075042-2FE9DD5D-6D6C-4BC9-84DC-B4AB76170DEFQ54517966-2E40E6CC-4F44-446B-B728-9429D6DA84B0Q55665338-6F34A061-64B9-45A3-8F00-44101A82850CQ57057499-64016EB7-8AD6-4095-A6D6-EEC04C750696
P2860
Chemotherapy-induced pulmonary hypertension: role of alkylating agents.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Chemotherapy-induced pulmonary hypertension: role of alkylating agents.
@en
type
label
Chemotherapy-induced pulmonary hypertension: role of alkylating agents.
@en
prefLabel
Chemotherapy-induced pulmonary hypertension: role of alkylating agents.
@en
P2093
P50
P1476
Chemotherapy-induced pulmonary hypertension: role of alkylating agents
@en
P2093
Edmund Lau
Gérald Simonneau
Kurt Stenmark
Laurent Savale
Nicolas Raymond
Sylvia Cohen-Kaminsky
Sébastien J Dumas
P304
P356
10.1016/J.AJPATH.2014.10.021
P407
P50
P577
2014-12-11T00:00:00Z